Alternatives to Gene Bio Medical

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Biotechnology company developing cell and gene therapies for serious diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotech company developing next-generation gene writing tools for advanced therapies.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Global marketplace connecting researchers with human biospecimens for life science research.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

AI-powered platform for antibody discovery and development to create new medicines.

Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

A biotechnology company developing genetic therapies for rare disorders.

Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases.

Biopharmaceutical company focused on rare genetic diseases of obesity.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Develops in vivo therapies to precisely engineer any targeted cell type within the human body.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Developing novel therapies for rare genetic disorders and unmet medical needs.

Developing gene editing therapies for rare genetic diseases.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Cloud-native platform for scalable and reproducible bioinformatics workflows.

Teknova provides critical reagents for biopharmaceutical product development and production.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Mapping cell-cell communication at scale in human tissue.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Genomic data analysis platform for rare diseases and cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.